Skip to main content

Peer Review reports

From: DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Original Submission
28 Jul 2015 Submitted Original manuscript
4 Sep 2015 Reviewed Reviewer Report - Lanjing Zhang
23 Sep 2015 Reviewed Reviewer Report - JIN LI
1 Oct 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
31 Oct 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 2
31 Oct 2015 Submitted Manuscript version 2
1 Dec 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 3
1 Dec 2015 Submitted Manuscript version 3
14 Dec 2015 Author responded Author comments - Thomas Ettrich
Resubmission - Version 4
14 Dec 2015 Submitted Manuscript version 4
Publishing
6 Jan 2016 Editorially accepted
15 Jan 2016 Article published 10.1186/s12885-016-2052-4

You can find further information about peer review here.

Back to article page